[go: up one dir, main page]

PL3274725T3 - Sposoby wykrywania apolipoprotein - Google Patents

Sposoby wykrywania apolipoprotein

Info

Publication number
PL3274725T3
PL3274725T3 PL16794966T PL16794966T PL3274725T3 PL 3274725 T3 PL3274725 T3 PL 3274725T3 PL 16794966 T PL16794966 T PL 16794966T PL 16794966 T PL16794966 T PL 16794966T PL 3274725 T3 PL3274725 T3 PL 3274725T3
Authority
PL
Poland
Prior art keywords
ways
apolipoprotein
detect
detect apolipoprotein
Prior art date
Application number
PL16794966T
Other languages
English (en)
Inventor
Andrés RODRÍGUEZ MARTÍN
Miguel CALERO LARA
Olga Calero Rueda
Luis GARCÍA ALBERT
Original Assignee
Biocross, S.L.
Instituto De Salud Carlos Iii
Centro De Investigacíon Biomédica En Red De Enfermedades Neurodegenerativas Ciberned
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocross, S.L., Instituto De Salud Carlos Iii, Centro De Investigacíon Biomédica En Red De Enfermedades Neurodegenerativas Ciberned filed Critical Biocross, S.L.
Publication of PL3274725T3 publication Critical patent/PL3274725T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
PL16794966T 2015-11-02 2016-11-02 Sposoby wykrywania apolipoprotein PL3274725T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15382537.7A EP3163303A1 (en) 2015-11-02 2015-11-02 Methods for apolipoprotein detection
PCT/EP2016/076457 WO2017076919A2 (en) 2015-11-02 2016-11-02 Methods for apolipoprotein detection
EP16794966.8A EP3274725B1 (en) 2015-11-02 2016-11-02 Methods for apolipoprotein detection

Publications (1)

Publication Number Publication Date
PL3274725T3 true PL3274725T3 (pl) 2019-08-30

Family

ID=54608470

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16794966T PL3274725T3 (pl) 2015-11-02 2016-11-02 Sposoby wykrywania apolipoprotein

Country Status (16)

Country Link
US (1) US20180313854A1 (pl)
EP (3) EP3163303A1 (pl)
JP (1) JP6994718B2 (pl)
KR (1) KR102630558B1 (pl)
CN (2) CN119199154A (pl)
AU (1) AU2016348558B2 (pl)
CA (1) CA3003837A1 (pl)
DK (1) DK3274725T3 (pl)
ES (1) ES2728268T3 (pl)
HU (1) HUE042606T2 (pl)
MX (1) MX382446B (pl)
PL (1) PL3274725T3 (pl)
PT (1) PT3274725T (pl)
RU (1) RU2763404C2 (pl)
TR (1) TR201904846T4 (pl)
WO (1) WO2017076919A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10921331B2 (en) * 2016-07-21 2021-02-16 Cleveland Heartlab, Inc. HDL-associated protein biomarker panel detection
JP7109597B2 (ja) * 2018-06-01 2022-07-29 ラボラトリー コーポレイション オブ アメリカ ホールディングス Lc-ms/msのための簡易化した生体試料の処理
CN109212218A (zh) * 2018-11-07 2019-01-15 李玉民 基于apoa4蛋白胃癌检测试剂盒、及其使用方法
US20220326258A1 (en) * 2019-09-13 2022-10-13 Northwestern University Biomarkers for amyotrophic lateral sclerosis (als) and motor neuron diseases
CN110780071A (zh) * 2019-11-11 2020-02-11 彭涛 一种乙肝相关肝细胞癌的预后检测试剂盒
CN112375138B (zh) * 2020-11-13 2022-12-13 中元汇吉生物技术股份有限公司 一种重组载脂蛋白e和应用
CN115541568B (zh) * 2021-06-29 2025-07-11 厦门红观生物科技有限公司 一种泪液试纸上ApoJ提取和定量检测方法及其试剂盒和应用
CN117886933A (zh) * 2023-12-28 2024-04-16 上海良润生物医药科技有限公司 一种载脂蛋白e检测试剂及其应用
WO2025219956A1 (en) * 2024-04-18 2025-10-23 Comed Therapeutics Ltd. Compositions and methods for rna delivery to cells

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772549A (en) * 1986-05-30 1988-09-20 Biotechnology Research Partners, Ltd. Polymorphisms related to lipid metabolism: ApoB, ApoCII, ApoE, ApoAIV
US5945289A (en) 1996-12-20 1999-08-31 Lehrer; Steven Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping
JP3397066B2 (ja) * 1996-12-27 2003-04-14 富士レビオ株式会社 免疫学的測定方法を用いたアポ蛋白eフェノタイプの同定方法
JP2002539458A (ja) * 1999-03-16 2002-11-19 セレックス, インコーポレイテッド 唾液中のapoaおよびapob、ならびにそれらの比を検出するための方法およびデバイス
DE60225821T2 (de) * 2001-10-04 2009-04-30 Immuno-Biological Laboratories Co., Ltd., Takasaki Reagens zum Nachweis eines Risikofaktors der Alzheimer-Krankheit, Nachweiskit dafür und Verfahren zum Nachweis eines Risikofaktors der Alzheimer-Krankheit unter ihrer Verwendung
WO2003070169A2 (en) * 2002-02-19 2003-08-28 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
US20050255498A1 (en) * 2004-01-22 2005-11-17 Genaissance Pharmaceuticals APOC1 genetic markers associated with age of onset of Alzheimer's Disease
JP5229789B2 (ja) * 2007-02-27 2013-07-03 プリマハム株式会社 新規ストレスバイオマーカー及びその用途
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
ES2364169B1 (es) * 2010-02-09 2012-07-10 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) Uso de las isoformas de apo j como biomarcadores de lesión tisular.
EP2542581A4 (en) * 2010-03-01 2014-01-22 David Gladstone Inst APOLIPOPROTEIN-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF
WO2012006329A2 (en) * 2010-07-06 2012-01-12 Genomind, Llc Apoe4 and apoj biomarker-based prevention and treatment of dementia
WO2013170057A2 (en) * 2012-05-09 2013-11-14 President And Fellows Of Harvard College Quantification of lipoproteins
EP2770326B1 (en) * 2013-02-26 2019-09-11 Instituto Oftalmologico Fernandez - Vega, S.L. Method for the diagnosis of glaucoma based on the determination of serum protein levels

Also Published As

Publication number Publication date
EP3274725B1 (en) 2019-01-09
RU2018120081A3 (pl) 2020-03-10
US20180313854A1 (en) 2018-11-01
EP3274725A2 (en) 2018-01-31
PT3274725T (pt) 2019-04-30
KR20180081545A (ko) 2018-07-16
MX382446B (es) 2025-03-13
RU2018120081A (ru) 2019-12-05
WO2017076919A3 (en) 2017-06-15
JP6994718B2 (ja) 2022-01-14
DK3274725T3 (en) 2019-04-23
EP3163303A1 (en) 2017-05-03
MX2018005448A (es) 2019-04-04
CN119199154A (zh) 2024-12-27
KR102630558B1 (ko) 2024-01-26
EP3457140A1 (en) 2019-03-20
BR112018008749A2 (pt) 2018-10-30
ES2728268T3 (es) 2019-10-23
JP2018533022A (ja) 2018-11-08
TR201904846T4 (tr) 2019-04-22
CA3003837A1 (en) 2017-05-11
CN108700593A (zh) 2018-10-23
AU2016348558B2 (en) 2022-02-24
RU2763404C2 (ru) 2021-12-28
BR112018008749A8 (pt) 2019-02-26
WO2017076919A2 (en) 2017-05-11
HUE042606T2 (hu) 2019-07-29
AU2016348558A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
EP3359930A4 (en) MULTISENSOR
DK4032440T3 (da) Låganordning
EP3923593C0 (en) AREA RECONNAISSANCE
CL2015003638S1 (es) Motocicleta
CL2016000865S1 (es) Motocicleta
CL2016001107S1 (es) Motocicleta
LT3149345T (lt) Būdas dviem objektams sujungti
FI20145680A7 (fi) Anturijärjestely
PL3274725T3 (pl) Sposoby wykrywania apolipoprotein
KR20180084915A (ko) 구조체
DK3110442T3 (da) Modificerede meningokok-fhbp-polypeptider
PT3341725T (pt) Métodos para detetar alfa-sinucleína fosforilada
CL2016000754S1 (es) Triciclo
CL2016000560S1 (es) Motocicleta
EP3343603A4 (en) STRUCTURE
EP3343641A4 (en) PHOTO DETECTOR
DK3296597T3 (da) Krydshovedmotor
DK3176063T3 (da) Trehjulet cykel
MA41266A (fr) Cataplasme
EP3384016A4 (en) MANIPULATED PHAGEMIDES
FI20146118L (fi) Katamaraani
DK3286193T3 (da) Indolderivater
FR3022212B1 (fr) Tricycle utilitaire ameliore
ITUB20160950A1 (it) Motociclo
ES1107755Y (es) Horquilla mejorada